Literature DB >> 27448218

[Glaucoma-a common disease].

I Oberacher-Velten1, E Hoffmann2, H Helbig3.   

Abstract

Glaucoma is the second leading cause of blindness worldwide. The purpose of this paper is to give a review on the epidemiology of the disease, on the importance and the consequences of glaucoma for people regarding their daily life, their ability to work, and quality of life.

Entities:  

Keywords:  Blindness; Employment; Epidemiology; Quality of life; Screening

Mesh：

Year:  2016        PMID： 27448218     DOI： 10.1007/s00347-016-0325-6

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


  26 in total

1.  Discrimination of Glaucoma Patients From Healthy Individuals Using Combined Parameters From Spectral-domain Optical Coherence Tomography in an African American Population.

Authors:  Dana M Blumberg; Elizabeth Dale; Noelle Pensec; George A Cioffi; Nathan Radcliffe; Michelle Pham; Lama Al-Aswad; Margaret Reynolds; Adam Ciarleglio
Journal:  J Glaucoma       Date:  2016-03       Impact factor: 2.503

2.  Comparison of different spectral domain OCT scanning protocols for diagnosing preperimetric glaucoma.

Authors:  Renato Lisboa; Augusto Paranhos; Robert N Weinreb; Linda M Zangwill; Mauro T Leite; Felipe A Medeiros
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-13       Impact factor: 4.799

3.  Optic disc morphometry in chronic primary open-angle glaucoma. II. Correlation of the intrapapillary morphometric data to visual field indices.

Authors:  J B Jonas; G C Gusek; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

4.  Combined evaluation of frequency doubling technology perimetry and scanning laser ophthalmoscopy for glaucoma detection using automated classification.

Authors:  Folkert K Horn; Robert Lämmer; Christian Y Mardin; Anselm G Jünemann; Georg Michelson; Berthold Lausen; Werner Adler
Journal:  J Glaucoma       Date:  2012-01       Impact factor: 2.503

5.  Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study.

Authors:  Stefano Miglior; Norbert Pfeiffer; Valter Torri; Thierry Zeyen; Jose Cunha-Vaz; Ingrid Adamsons
Journal:  Ophthalmology       Date:  2006-10-27       Impact factor: 12.079

6.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

7.  From clinical examination of the optic disc to clinical assessment of the optic nerve head: a paradigm change.

Authors:  Balwantray C Chauhan; Claude F Burgoyne
Journal:  Am J Ophthalmol       Date:  2013-06-12       Impact factor: 5.258

Review 8.  Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.

Authors:  Yih-Chung Tham; Xiang Li; Tien Y Wong; Harry A Quigley; Tin Aung; Ching-Yu Cheng
Journal:  Ophthalmology       Date:  2014-06-26       Impact factor: 12.079

9.  Optic disc morphometry in chronic primary open-angle glaucoma. I. Morphometric intrapapillary characteristics.

Authors:  J B Jonas; G C Gusek; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

10.  Peripapillary retinal nerve fiber layer assessment of spectral domain optical coherence tomography and scanning laser polarimetry to diagnose preperimetric glaucoma.

Authors:  Harsha L Rao; Ravi K Yadav; Uday K Addepalli; Shashikant Chaudhary; Sirisha Senthil; Nikhil S Choudhari; Chandra S Garudadri
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240
View more
  1 in total

1.  The association between socioeconomic status and visual impairments among primary glaucoma: the results from Nationwide Korean National Health Insurance Cohort from 2004 to 2013.

Authors:  Haejune Sung; Hyun Ho Shin; Yunseng Baek; Gyu Ah Kim; Jae Sang Koh; Eun-Cheol Park; Jaeyong Shin
Journal:  BMC Ophthalmol       Date:  2017-08-23       Impact factor: 2.209
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.